Elysium Health, a consumer health company that develops dietary supplements, secured a $5 million credit facility from Silicon Valley Bank.

The credit facility is a working capital line of credit for up to $5 million that can be used for general corporate purposes and to support growth.

“Elysium Health is committed to bringing evidence-based supplements to market that enable people to take a proactive role in managing their health,” said Eric Marcotulli, co-founder and CEO of Elysium Health. “Our financial agreement with Silicon Valley Bank reflects the confidence the SVB team has in our growth potential, and we look forward to further advancing meaningful scientific breakthroughs.”

“Elysium Health aims to fundamentally change the way we think about health and wellness,” said Melissa Stepanis, New York market manager for Silicon Valley Bank. “We’re pleased to support the Elysium Health team as the company matures and advances its innovative vision.”

The credit facility follows the $20 million Series B financing Elysium announced in December 2016.